Continuation of Milnacipran Therapy During Pregnancy in a Patient with Severe PTSD and Psychotic Depression: A Case Study with Three-Year Pediatric Outcomes - Takeaways - MDSpire

Continuation of Milnacipran Therapy During Pregnancy in a Patient with Severe PTSD and Psychotic Depression: A Case Study with Three-Year Pediatric Outcomes

  • By

  • Maximilian Preiss

  • Lucie Bartova

  • April 27, 2026

  • 0 min

Share

  • 1

    Milnacipran was effective for a 31-year-old woman with severe PTSD and psychotic depression before pregnancy, leading to marked clinical improvement.

  • 2

    After pregnancy confirmation, milnacipran was switched to sertraline and quetiapine due to limited safety data, but depressive symptoms quickly returned.

  • 3

    Milnacipran was resumed after a risk-benefit evaluation, resulting in renewed improvement in the patient's mental health.

  • 4

    Moderate hyperemesis gravidarum led to discontinuation of milnacipran by gestational week 22, with delivery occurring at week 38 via cesarean section.

  • 5

    At three-year follow-up, pediatric developmental screenings showed no significant issues, indicating favorable outcomes despite maternal treatment challenges.

Original Source(s)

Continuation of Milnacipran Therapy During Pregnancy in a Patient with Severe PTSD and Psychotic Depression: A Case Study with Three-Year Pediatric Outcomes

  • by Maximilian Preiss, Lucie Bartova

  • April 27, 2026

Related Content

Artificial Intelligence Centrality in Psychotic Delusions and Violence Risk in Forensic Psychiatry: Retrospective Observational Study of Judicial Decisions

Retraction: Impaired potentiation of theta oscillations during a visual cortical plasticity paradigm in individuals with schizophrenia

  • May 6, 2026

Cognitive impairment and associated factors in elderly patients with schizophrenia: a retrospective observational study with phenotype analysis